Cardiovascular Diseases Clinical Trial
Official title:
A Study of the Implementation of an Electronic Consultation ("eConsult") Platform to Increase Specialist Access for Patients in Underserved Populations: Impact on Provider Experience, Wait Times and Cost
The purpose of this study is to evaluate the implementation of an electronic consultation model for specialty services (eConsults) to improve quality of care and reduce health system costs. An eConsult is a non-face-to-face consultation between a primary care provider and a specialist that takes place via secure messaging.
The study is a randomized, controlled trial where the intervention is the evidence-based
eConsult model in which consults are submitted by electronic, secure messaging to a
specialist for review and "virtual" consultation. Primary Care Providers will be randomized
to the control or intervention group. In the intervention group, ALL new, non urgent, adult
cardiology referrals will be submitted to the eConsult Cardiology team for an eConsult.
Consults for children (age <18) and consults for patients who already have an established
relationship with another cardiologist will not be eligible for an eConsult. Urgent
consults, such as those for patients with active chest pain or other acute conditions, will
not be submitted for eConsult and should instead be handled by the on-site care team as per
the standard protocol. For eConsults, the consult will be submitted using the eConsult
pathway within the electronic health record. eConsults will be created in the same way that
standard referrals are created, with attachment of a treatment summary, EKG, relevant
results, and specification of the consultative question. The eConsult will be received by
the intervention Cardiology team and reviewed within 2 business days. One cardiologist per
day will be assigned to review and respond to eConsults.
The result will be received by the primary care provider who will be responsible for acting
appropriately on the cardiologist's recommendations. Recommendations will be case specific
and may include one of three broad areas of suggestion: 1) suggestions for ongoing
management by the primary care provider, 2) suggestions for additional testing in advance of
a cardiology face to face appointment or to better determine a next course of action, and 3)
immediate cardiology referral.
For each of these options, the primary care provider will be responsible for following up
and implementing the recommendations made by the Cardiologist. When referral is recommended
the primary care provider will refer the patient to the cardiologist of their choice based
on their location and the patient's preference. While not required, they may refer the
patient to the eConsult cardiology team at University of Connecticut for face to face care
if desirable, but may also refer to other Cardiologists. The intervention will last one
year. Providers randomized to the control group will provide standard care which involves a
traditional referral for an in-person cardiology visit.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|